Actavis in talks to buy Allergan for at least $60 billion: Bloomberg
November 12, 2014 at 10:29 AM EST
(Reuters) - Actavis Plc is in talks to buy Allergan Inc for at least $60 billion in a deal that could culminate this month, Bloomberg reported, citing sources familiar with the matter.
